drugset / Trial / NCT04201951
Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women
RandomizedParallel-groupTriple-blindPrevention
Summary
Postpartum hemorrhage and its complications are very well known causes for maternal mortality .Uterine atony is the most common cause for postpartum hemorrhage
Timeline
- Start
- 2020-02-01
- Primary completion
- 2020-10-10
- Completion
- 2020-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 1 g | Intravenous |
Indications
No indication recorded.